-velk1n - FACEIT level 10, 2,321 ELO

Russia
On FACEIT since 2023 191 matches tracked 71 matches in 30 days
ELO ▼ 71
2,321
30-day peak: 2,392
Rank EU
#97,126
Russia #27,360 in Russia
Last updated:

-velk1n at a glance

Level 10 2,321 ELO best map Nuke (67%)
2,250-2,499 ELO

Last 20 matches compared with 2,995 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 8%
0.88
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.23 ConsistencyShare of matches with a rating of 0.90 or higher. 40%
K/R
0.61
better than 5% of players
2,250-2,499 ELO avg: 0.74
Last 12 months
ADR
70.1
better than 7% of players
2,250-2,499 ELO avg: 81.0
Last 12 months
Win rate
50%
better than 44% of players
2,250-2,499 ELO avg: 51%
Last 12 months

Facts

272 ELO Next goal ELO to the peak (2,593)
6 Comebacks last 90 days
6 W · 3 L Overtime in overtime
Mirage Favorite map 63 of 191 matches
Nuke 67% Map pool tip weakest: Ancient 38%
5 knife kills Rare kills last 90 days
On Tuesdays Playing times most active
6:00-12:00 Best time 58% win rate vs. 47%
FormMapsTiming

272 ELO away from the recorded peak (2,593). 6 wins after trailing at halftime (last 90 days). 9 matches in overtime, 6 of them won (last 90 days). Most played: Mirage (63 of 191 matches). Strongest map: Nuke (67% win rate, 18 matches). Weakest: Ancient (38%, 26 matches). 5 knife kills (last 90 days). Plays most on Tuesdays (based on 191 matches). Best results between 6:00 and 12:00: 58% win rate vs. 47% overall (26 matches).

About -velk1n

-velk1n plays CS2 on FACEIT level 10 with 2,321 ELO. The stats cover 191 matches. The strongest map is Nuke with a 67% win rate in 18 matches. Most played: Mirage with 63 matches and a 44% win rate. -velk1n won 6 matches after trailing at halftime (last 90 days). Last 20 matches: 10 wins, 10 losses, +105 ELO. -velk1n does best between 6:00 and 12:00: 58% win rate in 26 matches.